BIOCON LTD. - Updates

	< Back
12 Jan 2015
With reference to the earlier Press Release dated September 18, 2014, Biocon Ltd has now informed BSE that M/s. Silver Leaf Oak (Mauritius) Limited has assigned its rights and obligations for acquisition of 10% stake in Syngene International Limited ('Syngene') to M/s IVF Trustee Company Private Limited ('IVF'), a fund advised by India Value Fund Advisors. Biocon Research Limited, a wholly owned subsidiary of the Company has concluded such sale to IVF. Post conclusion of the above, Biocon and BRL jointly hold 85.54% stake in Syngene.
View all announcements for BIOCON LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us